hypertensive patients who were
also diabetic. Several of those patients became extremely ill, one of
them close to death, though he eventually recovered."
Celia whisked another paper from her file. "A competitor of ours has an
antibiotic, Chloromycetin, again a first-rate drug, but for serious
infections only, since its possible side effects include damaging, even
fatal, blood disorders. Yet-and again I have dates, names, places-the
other company's detail men have assured doctors the drug is harmless .
. ."
Celia finished with Chloromycetin, then continued, "Now to comeback to
Felding-Roth . . ."
As she talked, the damning evidence mounted.
"I could go on," Celia said after a while, "but I won't because my file
is here for anyone in this company to examine. I will answer that second
question, though: Why did I bring this up today?
"I brought it up because I could not get attention any other way. I have
tried since last year to have someone at headquarters listen to me and
go through my file. No one would. I had the strong
63
impression that what I had accumulated was simply bad news that nobody
wanted to hear."
Now Celia looked down directly at the two executive rows. "It may be said
that what I have done today is headstrong, even foolish. Perhaps it is.
But I would like to say that I have done it out of deep conviction and
caring-for this company, our industry, and the reputation of both.
"That reputation is being tarnished, yet we are doing little or nothing
about it. As most of us know, there are hearings being held at present
in the U.S. Congress about the pharmaceutical industry. Those hearings
are antagonistic to us, yet few in the industry appear to be taking them
seriously. But they are serious. Already the press is giving prominence
to criticisms; soon there will be a public outcry for reform. I believe
that unless we do something ourselves to improve our sales practices and
reputation we shall have it done for us by government-in a way that none
of us will like and that will be harmful to us all.
"Finally, for all these reasons I urge that our own company take the
lead-first in establishing a detailing code of ethics, second in setting
up a training and retraining program for us detail people. I have put
together my own ideas for such a program." Celia paused and smiled. "If
anyone is interested, they too are in my file."
She concluded, "Thank you, and good afternoon."
As Celia gathered up her papers and moved to leave the speakers'
platform, there was some feeble handclapping, though it ceased almost at
once, with few in the audience seeming inclined to join in. Clearly, most
were taking their cue from the executive group at the front, from where
there was no applause and facial expressions showed disapproval. The
board chairman seemed angry-he was speaking in low tones, heatedly, to
Eli Camperdown; the FeldingRoth president nodding as he listened.
The vice president of sales, a New Yorker named Irving Gregson who had
been recently promoted, approached her. A forceful man of athletic build,
Gregson was normally genial and well liked- But now he was glowering, his
face flushed. "Young woman," he declared, "you have been malicious,
presumptuous and misguided; also your so-called facts are wrong. You are
going to regret it. You will be dealt with later, but for now, I am
ordering you to leave this sales convention and not to return."
"Sir," Celia said, "won't you at least look at the material I have-"
64
"I'll look at nothing!" Gregson's raised voice was audible through the
hall. "Get out of herel"
"Good afternoon, Mr. Gregson," Celia said. She turned and walked away,
heading for an exit. Her step was firm, head high. She thought, later there
would be time for regrets, perhaps deep dejection; for now, she had no
intention of leaving this male assemblage defeated, like a weakling. Just
the same, she admitted to herself, she was defeated, and of course
Kody Brown, Meri Brown, Janelle Brown, Christine Brown, Robyn Brown
Jrgen Osterhammel Patrick Camiller